Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Anne-Laure Marchal"'
Autor:
Michele Moschetta, Jaclyn Davis, Darlene Lu, Laure Moutouh-de Parseval, Luisa Mariconti, Xu Zhu, Nicolas Boissel, Attilio Bondanza, Leyla Shune, Michael Dickinson, Ulrich Jaeger, Boris Engels, Pere Barba, Javier Briones, Anne Laure Marchal, Didier Blaise, Ian W. Flinn, Jennifer Brogdon, Nirav N. Shah, Jennifer Marie Mataraza
Publikováno v:
Blood. 138:740-740
Background: Despite unprecedented efficacy of existing CAR-T cell therapy, many pts fail to respond to the therapy, or relapse after initial response. YTB323 is an autologous CD19-directed CAR-T cell therapy utilizing the FMC63 domain for CD19 recogn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f2b7be1ef6ae903a5571cf8ea810b48
https://doi.org/10.1182/blood-2021-146268
https://doi.org/10.1182/blood-2021-146268
Autor:
Janna Sand-Dejmek, Andrés Cervantes, Shuqi Chen, Miguel Martín, Jincheng Wu, Anne-Laure Marchal, Guillaume Baneyx, Jennifer Marie Mataraza, David Quinn
Publikováno v:
Cancer Research. 81:LB061-LB061
Background: The CSF-1/CSF-1R (colony-stimulating factor-1) pathway plays a significant role in the tumor microenvironment via regulation of tumor-associated macrophages (TAMs). Lacnotuzumab (MCS110) is a humanized monoclonal antibody against CSF-1. L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c7fbab2e05652abf32bf669f1b7d905
https://doi.org/10.1158/1538-7445.am2021-lb061
https://doi.org/10.1158/1538-7445.am2021-lb061